Want the key stats in the sections on this page as a document? or looking for a stats report of the in-depth stats? Use the print function at the bottom of any Cancer Stats page Share this page > Print or your browser options to print or save.
Uterine cancer statistics
New cases of uterine cancer, 2015, UK
Deaths from uterine cancer, 2016, UK
Survive uterine cancer for 10 or more years, 2010-11, England and Wales
Uterine cancer cases are preventable, UK, 2015
- There are around 9,100 new uterine cancer cases in the UK every year, that's 25 every day (2013-2015).
- In females in the UK, uterine cancer is the 4th most common cancer, with around 9,000 new cases in 2015.
- Uterine cancer accounts for 5% of all new cancer cases in females in the UK (2015).
- Incidence rates for uterine cancer in the UK are highest in females aged 75 to 79 (2013-2015).
- Since the early 1990s, uterine cancer incidence rates have increased by almost three-fifths (56%) in females in the UK.
- Over the last decade, uterine cancer incidence rates have increased by around a fifth (21%) in females in the UK.
- Around a fifth of uterine cancer cases are diagnosed at a late stage in England (2014) and Northern Ireland (2010-2014).
- Most uterine cancers occur in the endometrium.
- Incidence rates for uterine cancer are projected to fall by 7% in the UK between 2014 and 2035, to 33 cases per 100,000 females by 2035.
- Uterine cancer incidence in England is not associated with deprivation.
- Uterine cancer is as common in White, Asian and Black females.
- An estimated 70,200 women who had previously been diagnosed with uterine cancer were alive in the UK at the end of 2010.
- There are around 2,200 uterine cancer deaths in the UK every year, that's around 6 every day (2014-2016).
- In females in the UK, uterine cancer is the 8th most common cause of cancer death, with around 2,400 deaths in 2016.
- Uterine cancer accounts for 3% of all cancer deaths in females in the UK (2016).
- Mortality rates for uterine cancer in the UK are highest in females aged 90+ (2014-2016).
- Since the early 1970s, uterine cancer mortality rates have remained stable in females in the UK.
- Over the last decade, uterine cancer mortality rates have increased by around a fifth (21%) in females in the UK.
- Mortality rates for uterine cancer are projected to rise by 19% in the UK between 2014 and 2035, to 9 deaths per 100,000 females by 2035.
- Uterine cancer deaths in England are more common in females living in the most deprived areas.
- Almost 7 in 10 (78%) women diagnosed with uterine cancer in England and Wales survive their disease for ten years or more (2010-11).
- Around 8 in 10 (79%) women diagnosed with uterine cancer in England and Wales survive their disease for five years or more (2010-11).
- 9 in 10 (90%) women diagnosed with uterine cancer in England and Wales survive their disease for one year or more (2010-11).
- Almost 9 in 10 women in England diagnosed with uterine cancer aged 15-39 survive their disease for five years or more, compared with less than 6 in 10 women diagnosed aged 80 and over (2009-2013).
- Uterine cancer survival is improving and has increased in the last 40 years in the UK.
- In the 1970s, almost 6 in 10 women diagnosed with uterine cancer survived their disease beyond ten years, now it's almost 8 in 10.
- When diagnosed at its earliest stage, 95% of women with uterine cancer will survive their disease for five years or more, compared with around 3 in 20 women when diagnosed at the latest stage.
- Five-year relative survival for uterine cancer in women is similar to the European average in England, Wales, Scotland and Northern Ireland.
- A person’s risk of developing cancer depends on many factors, including age, genetics, and exposure to risk factors (including some potentially avoidable lifestyle factors).
- 1 in 36 UK females will be diagnosed with uterine cancer in their lifetime.
- 34% of uterine cancer cases in the UK are preventable.
- 'Two-week wait' is the most common route to diagnosing uterine cancer.
- GP referral is the route with the highest proportion of cases diagnosed at an early stage, for uterine cancer.
- 'Two-week wait’ standards are met by all countries, ‘31-day wait’ is met by all but Northern Ireland and Wales, and ’62-day wait’ is met by all but Wales, Northern Ireland and only partly by Scotland for gynaecological cancers.
- Around 8 in 10 uterine cancer patients receive major surgical resection as part of their cancer treatment.
- 21% of patients diagnosed with uterine cancer have radiotherapy as part of their primary cancer treatment.
- 16% of patients diagnosed with uterine cancer have chemotherapy as part of their primary cancer treatment.
The latest statistics available for uterine cancer in the UK are; incidence 2015, mortality 2016 and survival 2010-2011 (all ages combined) and 2009-2013 (by age).
Uterine cancer is sometimes called womb cancer, and is occasionally reported as body of the uterus (C54) alone.
European Age-Standardised Rates were calculated using the 1976 European Standard Population (ESP) unless otherwise stated as calculated with ESP2013. ASRs calculated with ESP2013 are not comparable with ASRs calculated with ESP1976.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages,
Most cases of uterine cancer are in the endometrium; accordingly most evidence cited on our risk factors page is for endometrial cancer specifically rather than uterine cancer overall. The specific cancer type is stated where possible.
Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2012-2013. Staging proportions only include patients with a known stage (cases with an unknown stage at diagnosis are not included in the denominator).
Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Uterine cancer is part of the group 'Gynaecological cancer' for cancer waiting times data. Codes vary per country but broadly include: Vulva, vagina, cervix, uterus, ovary, other female genital organs, placenta and secondary cancers of ovary.
Cancer surgical resection rates data is for patients diagnosed in England between 2006 and 2010.
Patient Experience data is for adult patients in England with a primary diagnosis of cancer, who were in active treatment between September and November 2013 and who completed a survey in 2014.
Deprivation gradient statistics were calculated using incidence data for three time periods: 1996-2000, 2001-2005 and 2006-2010 and for mortality for two time periods: 2002-2006 and 2007-2011. The 1997-2001 mortality data were only used for the all cancers combined group as this time period includes the change in coding from ICD-9 to ICD-10. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.
You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:
Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.
When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or
We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.